Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	ARM-type_fold	USP34 BZW2 SCYL3 CUL9 PSMD5 ZNFX1 APOB DNAAF5 PPP2R1A PLAA MROH1 PSME4 MRO CEBPZ	6.78e-07	339	151	14	IPR016024
Domain	C1_1	UNC13B CDC42BPG PRKD3 PRKCH PRKCI UNC13A	6.53e-06	57	151	6	PF00130
Domain	HEAT_type_2	SCYL3 DNAAF5 PPP2R1A MROH1	9.00e-06	17	151	4	IPR021133
Domain	ZF_DAG_PE_1	UNC13B CDC42BPG PRKD3 PRKCH PRKCI UNC13A	1.29e-05	64	151	6	PS00479
Domain	ZF_DAG_PE_2	UNC13B CDC42BPG PRKD3 PRKCH PRKCI UNC13A	1.29e-05	64	151	6	PS50081
Domain	C1	UNC13B CDC42BPG PRKD3 PRKCH PRKCI UNC13A	1.41e-05	65	151	6	SM00109
Domain	PE/DAG-bd	UNC13B CDC42BPG PRKD3 PRKCH PRKCI UNC13A	1.54e-05	66	151	6	IPR002219
Domain	HEAT_REPEAT	SCYL3 DNAAF5 PPP2R1A MROH1 PSME4 MRO	2.16e-05	70	151	6	PS50077
Domain	HEAT	SCYL3 DNAAF5 PPP2R1A MROH1 MRO	1.05e-04	58	151	5	IPR000357
Domain	EGF	LAMA1 LAMC3 HMCN1 TIE1 TLL1 EGFL7 VWA2 AGRN TNXB	1.27e-04	235	151	9	SM00181
Domain	Unc-13	UNC13B UNC13A	1.94e-04	3	151	2	IPR027080
Domain	-	RASA4 RASA4B	1.94e-04	3	151	2	4.10.1130.10
Domain	EGF-like_dom	LAMA1 LAMC3 HMCN1 TIE1 TLL1 EGFL7 VWA2 AGRN TNXB	1.96e-04	249	151	9	IPR000742
Domain	EGF_1	LAMA1 LAMC3 HMCN1 TIE1 TLL1 EGFL7 VWA2 AGRN TNXB	2.34e-04	255	151	9	PS00022
Domain	EGF-like_CS	LAMA1 LAMC3 HMCN1 TIE1 TLL1 EGFL7 VWA2 AGRN TNXB	2.78e-04	261	151	9	IPR013032
Domain	EGF_2	LAMA1 LAMC3 HMCN1 TIE1 TLL1 EGFL7 VWA2 AGRN TNXB	3.11e-04	265	151	9	PS01186
Domain	ARM-like	SCYL3 CUL9 PSMD5 DNAAF5 PPP2R1A PLAA MROH1 PSME4 MRO	3.57e-04	270	151	9	IPR011989
Domain	LamG	LAMA1 TSPEAR COL5A3 AGRN	4.33e-04	44	151	4	SM00282
Domain	-	SCYL3 CUL9 PSMD5 DNAAF5 PPP2R1A MROH1 PSME4 MRO	4.55e-04	222	151	8	1.25.10.10
Domain	EGF	HMCN1 TIE1 TLL1 VWA2 AGRN TNXB	5.61e-04	126	151	6	PF00008
Domain	HEAT	SCYL3 DNAAF5 PPP2R1A MROH1	6.06e-04	48	151	4	PF02985
Domain	DAG/PE-bd	PRKD3 PRKCH PRKCI	6.19e-04	21	151	3	IPR020454
Domain	Munc13_dom-2	UNC13B UNC13A	6.39e-04	5	151	2	IPR014772
Domain	MHD2	UNC13B UNC13A	6.39e-04	5	151	2	PS51259
Domain	Munc13_subgr_dom-2	UNC13B UNC13A	6.39e-04	5	151	2	IPR019558
Domain	Membr_traf_MHD	UNC13B UNC13A	6.39e-04	5	151	2	PF10540
Domain	DUF1041	UNC13B UNC13A	6.39e-04	5	151	2	SM01145
Domain	Galactose-bd-like	MYCBP2 LAMA1 DCBLD1 CUL9 LAMC3	9.95e-04	94	151	5	IPR008979
Domain	Laminin_G	LAMA1 TSPEAR COL5A3 AGRN	1.24e-03	58	151	4	IPR001791
Domain	LRR	LRRC32 KERA LINGO2 TLR6 LRFN5 LRRC61 CEP97	1.26e-03	201	151	7	PS51450
Domain	Munc13_1	UNC13B UNC13A	1.33e-03	7	151	2	IPR014770
Domain	APC_su10/DOC_dom	MYCBP2 CUL9	1.33e-03	7	151	2	IPR004939
Domain	MHD1	UNC13B UNC13A	1.33e-03	7	151	2	PS51258
Domain	DOC	MYCBP2 CUL9	1.33e-03	7	151	2	PS51284
Domain	ANAPC10	MYCBP2 CUL9	1.33e-03	7	151	2	PF03256
Domain	DUF1041	UNC13B UNC13A	1.33e-03	7	151	2	PF06292
Domain	CAPS_dom	UNC13B UNC13A	1.33e-03	7	151	2	IPR010439
Domain	APC10	MYCBP2 CUL9	1.33e-03	7	151	2	SM01337
Domain	Growth_fac_rcpt_	LAMA1 LAMC3 HMCN1 TIE1 EGFL7 TNXB	1.70e-03	156	151	6	IPR009030
Domain	LAMININ_IVA	LAMA1 LAMC3	1.76e-03	8	151	2	PS51115
Domain	Laminin_B	LAMA1 LAMC3	1.76e-03	8	151	2	PF00052
Domain	LamB	LAMA1 LAMC3	1.76e-03	8	151	2	SM00281
Domain	Laminin_IV	LAMA1 LAMC3	1.76e-03	8	151	2	IPR000034
Domain	Helicase_C	DDX31 DDX49 FANCM DDX25 ERCC6L2	1.77e-03	107	151	5	PF00271
Domain	HELICc	DDX31 DDX49 FANCM DDX25 ERCC6L2	1.77e-03	107	151	5	SM00490
Domain	EGF_LAM_2	LAMA1 LAMC3 AGRN	1.79e-03	30	151	3	PS50027
Domain	EGF_LAM_1	LAMA1 LAMC3 AGRN	1.79e-03	30	151	3	PS01248
Domain	Helicase_C	DDX31 DDX49 FANCM DDX25 ERCC6L2	1.85e-03	108	151	5	IPR001650
Domain	HELICASE_CTER	DDX31 DDX49 FANCM DDX25 ERCC6L2	1.92e-03	109	151	5	PS51194
Domain	HELICASE_ATP_BIND_1	DDX31 DDX49 FANCM DDX25 ERCC6L2	1.92e-03	109	151	5	PS51192
Domain	DEXDc	DDX31 DDX49 FANCM DDX25 ERCC6L2	1.92e-03	109	151	5	SM00487
Domain	DEAD_ATP_HELICASE	DDX31 DDX49 DDX25	1.97e-03	31	151	3	PS00039
Domain	Helicase_ATP-bd	DDX31 DDX49 FANCM DDX25 ERCC6L2	2.00e-03	110	151	5	IPR014001
Domain	LRR_1	LRRC32 KERA LINGO2 TLR6 LRFN5 LRRC61 CEP97	2.05e-03	219	151	7	PF00560
Domain	BTK	RASA4 RASA4B	2.25e-03	9	151	2	SM00107
Domain	Znf_Btk_motif	RASA4 RASA4B	2.25e-03	9	151	2	IPR001562
Domain	BTK	RASA4 RASA4B	2.25e-03	9	151	2	PF00779
Domain	ZF_BTK	RASA4 RASA4B	2.25e-03	9	151	2	PS51113
Domain	RNA-helicase_DEAD-box_CS	DDX31 DDX49 DDX25	2.37e-03	33	151	3	IPR000629
Domain	EGF_Lam	LAMA1 LAMC3 AGRN	2.80e-03	35	151	3	SM00180
Domain	Laminin_EGF	LAMA1 LAMC3 AGRN	2.80e-03	35	151	3	PF00053
Domain	-	MYCBP2 DCBLD1 CUL9 LAMC3	2.90e-03	73	151	4	2.60.120.260
Domain	DEAD/DEAH_box_helicase_dom	DDX31 DDX49 FANCM DDX25	2.90e-03	73	151	4	IPR011545
Domain	DEAD	DDX31 DDX49 FANCM DDX25	2.90e-03	73	151	4	PF00270
Domain	EGF_3	HMCN1 TIE1 TLL1 EGFL7 VWA2 AGRN TNXB	3.05e-03	235	151	7	PS50026
Domain	EGF_CA	HMCN1 TLL1 EGFL7 VWA2 AGRN	3.14e-03	122	151	5	SM00179
Domain	Pkinase_C	CDC42BPG PRKCH PRKCI	3.29e-03	37	151	3	IPR017892
Domain	Q_MOTIF	DDX31 DDX49 DDX25	3.29e-03	37	151	3	PS51195
Domain	RNA_helicase_DEAD_Q_motif	DDX31 DDX49 DDX25	3.29e-03	37	151	3	IPR014014
Domain	EGF-like_Ca-bd_dom	HMCN1 TLL1 EGFL7 VWA2 AGRN	3.37e-03	124	151	5	IPR001881
Domain	Filamin	MYCBP2 AREL1	3.40e-03	11	151	2	PF00630
Domain	FILAMIN_REPEAT	MYCBP2 AREL1	3.40e-03	11	151	2	PS50194
Domain	NC1_FIB	COL2A1 COL5A3	3.40e-03	11	151	2	PS51461
Domain	Filamin/ABP280_rpt	MYCBP2 AREL1	3.40e-03	11	151	2	IPR001298
Domain	Fib_collagen_C	COL2A1 COL5A3	3.40e-03	11	151	2	PD002078
Domain	Filamin/ABP280_repeat-like	MYCBP2 AREL1	3.40e-03	11	151	2	IPR017868
Domain	Fib_collagen_C	COL2A1 COL5A3	3.40e-03	11	151	2	IPR000885
Domain	COLFI	COL2A1 COL5A3	3.40e-03	11	151	2	PF01410
Domain	Laminin_G_1	LAMA1 AGRN	3.40e-03	11	151	2	PF00054
Domain	COLFI	COL2A1 COL5A3	3.40e-03	11	151	2	SM00038
Domain	Laminin_EGF	LAMA1 LAMC3 AGRN	3.55e-03	38	151	3	IPR002049
Domain	C2	UNC13B RASA4 RASA4B PRKCH UNC13A	4.25e-03	131	151	5	PF00168
Domain	Ig_I-set	IGFN1 LINGO2 HMCN1 LRFN5 CD101 IGLON5	4.52e-03	190	151	6	IPR013098
Domain	I-set	IGFN1 LINGO2 HMCN1 LRFN5 CD101 IGLON5	4.52e-03	190	151	6	PF07679
Domain	Pkinase_C	CDC42BPG PRKCH PRKCI	4.72e-03	42	151	3	PF00433
Domain	C2	UNC13B RASA4 RASA4B PRKCH UNC13A	5.14e-03	137	151	5	SM00239
Domain	RasGAP	RASA4 RASA4B	5.54e-03	14	151	2	SM00323
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH11	5.54e-03	14	151	2	IPR011704
Domain	SEA	MUC16 AGRN	5.54e-03	14	151	2	SM00200
Domain	RasGAP_CS	RASA4 RASA4B	5.54e-03	14	151	2	IPR023152
Domain	AAA_5	MDN1 DNAH11	5.54e-03	14	151	2	PF07728
Domain	C2	UNC13B RASA4 RASA4B PRKCH UNC13A	5.97e-03	142	151	5	PS50004
Domain	RasGAP	RASA4 RASA4B	6.36e-03	15	151	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	RASA4 RASA4B	6.36e-03	15	151	2	PS00509
Domain	-	MUC16 AGRN	6.36e-03	15	151	2	3.30.70.960
Domain	RAS_GTPASE_ACTIV_2	RASA4 RASA4B	6.36e-03	15	151	2	PS50018
Domain	Prot_kinase_dom	NRBP1 CDC42BPG PLK2 ABL2 SCYL3 PRKD3 JAK2 TIE1 PRKCH PRKCI	6.49e-03	489	151	10	IPR000719
Domain	Leu-rich_rpt	LRRC32 KERA LINGO2 TLR6 LRFN5 LRRC61 CEP97	6.59e-03	271	151	7	IPR001611
Domain	PROTEIN_KINASE_DOM	NRBP1 CDC42BPG PLK2 ABL2 SCYL3 PRKD3 JAK2 TIE1 PRKCH PRKCI	6.86e-03	493	151	10	PS50011
Domain	-	UNC13B RASA4 RASA4B PRKCH UNC13A	7.09e-03	148	151	5	2.60.40.150
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	COL2A1 LAMA1 COL5A3 LAMC3 ITGA4 AGRN TNXB	3.34e-06	84	107	7	M7098
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	COL2A1 LAMA1 COL5A3 LAMC3	7.39e-05	30	107	4	M27772
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	COL2A1 LAMA1 COL5A3 LAMC3 AGRN	8.29e-05	59	107	5	M27218
Pubmed	Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.	SHC1 JAK2 IL6ST	3.60e-07	4	157	3	9126968
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL2A1 ANXA5 LAMA1 COL5A3 HMCN1 EGFL7 AGRN TNXB	1.41e-06	175	157	8	28071719
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DDX49 COPA MYCBP2 ANXA5 TTC27 PSMD5 DPF2 PHF8 HNRNPL BLVRA CCNT1 PPP2R1A MDN1 PLAA PSME4 TCERG1 CEBPZ MGA AGRN SLC27A4	3.32e-06	1353	157	20	29467282
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	EMC1 DDX31 COPA MYCBP2 BZW2 SCYL3 SHC1 TTC27 PHF8 DTNBP1 HNRNPL PPP2R1A CEBPZ SUN2 PRKCI HERC1 NOS1AP	5.82e-06	1049	157	17	27880917
Pubmed	MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma.	JAK2 PPP2R1A IL6ST	7.43e-06	9	157	3	36112698
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	DYM EMC1 MYCBP2 BZW2 TTC27 PPP2R1A LARP4B MDN1 PLAA CEBPZ SUN2 YPEL5 PWP2 SLC27A4	9.05e-06	754	157	14	33060197
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	LAMA1 APOB HMCN1 AGRN TNXB	1.08e-05	64	157	5	22261194
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	UNC13B USP34 TBC1D9B MYCBP2 SHC1 CUL9 LAMC3 ABCA7 JAK2 EHBP1L1 MDN1 MROH1 PSME4 USP40 PCYT2 HERC1 AGRN	1.14e-05	1105	157	17	35748872
Pubmed	Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C.	PRKD3 PRKCH PRKCI	1.45e-05	11	157	3	2182321
Pubmed	In vitro phosphorylation of human immunodeficiency virus type 1 Tat protein by protein kinase C: evidence for the phosphorylation of amino acid residue serine-46.	PRKD3 PRKCH PRKCI	1.45e-05	11	157	3	8914829
Pubmed	HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta.	PRKD3 PRKCH PRKCI	1.93e-05	12	157	3	11919157
Pubmed	Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.	CFTR NOS2	2.02e-05	2	157	2	9739054
Pubmed	Regulation of insulin exocytosis by Munc13-1.	UNC13B UNC13A	2.02e-05	2	157	2	12871971
Pubmed	Formation of perineuronal nets in organotypic mouse brain slice cultures is independent of neuronal glutamatergic activity.	UNC13B UNC13A	2.02e-05	2	157	2	17561838
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	2.02e-05	2	157	2	11448776
Pubmed	Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming.	UNC13B UNC13A	2.02e-05	2	157	2	28489077
Pubmed	Mucin 16 Promotes Colorectal Cancer Development and Progression Through Activation of Janus Kinase 2.	MUC16 JAK2	2.02e-05	2	157	2	33982216
Pubmed	Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles.	UNC13B UNC13A	2.02e-05	2	157	2	10440375
Pubmed	Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin.	UNC13B UNC13A	2.02e-05	2	157	2	22066784
Pubmed	Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses.	UNC13B UNC13A	2.02e-05	2	157	2	32187536
Pubmed	GPHR-dependent functions of the Golgi apparatus are essential for the formation of lamellar granules and the skin barrier.	GPR89B GPR89A	2.02e-05	2	157	2	22572823
Pubmed	Role of mammalian homologue of Caenorhabditis elegans unc-13-1 (Munc13-1) in the recruitment of newcomer insulin granules in both first and second phases of glucose-stimulated insulin secretion in mouse islets.	UNC13B UNC13A	2.02e-05	2	157	2	22814762
Pubmed	Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release.	UNC13B UNC13A	2.02e-05	2	157	2	28426965
Pubmed	SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion.	CFTR SLC6A14	2.02e-05	2	157	2	30004386
Pubmed	Dynamic control of synaptic vesicle replenishment and short-term plasticity by Ca(2+)-calmodulin-Munc13-1 signaling.	UNC13B UNC13A	2.02e-05	2	157	2	23770256
Pubmed	Genetics of hearing loss: Allelism and modifier genes produce a phenotypic continuum.	WFS1 CDH23	2.02e-05	2	157	2	16550584
Pubmed	Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses.	UNC13B UNC13A	2.02e-05	2	157	2	31851910
Pubmed	GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus.	GPR89B GPR89A	2.02e-05	2	157	2	18794847
Pubmed	Differential control of vesicle priming and short-term plasticity by Munc13 isoforms.	UNC13B UNC13A	2.02e-05	2	157	2	11832228
Pubmed	Munc13 controls the location and efficiency of dense-core vesicle release in neurons.	UNC13B UNC13A	2.02e-05	2	157	2	23229896
Pubmed	Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's chloride channel function.	ANXA5 CFTR	2.02e-05	2	157	2	17869070
Pubmed	Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.	MUC16 JAK2	2.02e-05	2	157	2	25691062
Pubmed	Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming.	UNC13B UNC13A	2.02e-05	2	157	2	12070347
Pubmed	Identification of a regulatory cis-element within the 3'-untranslated region of the murine inducible nitric oxide synthase (iNOS) mRNA; interaction with heterogeneous nuclear ribonucleoproteins I and L and role in the iNOS gene expression.	HNRNPL NOS2	2.02e-05	2	157	2	16584775
Pubmed	Munc13 genotype regulates secretory amyloid precursor protein processing via postsynaptic glutamate receptors.	UNC13B UNC13A	2.02e-05	2	157	2	23070049
Pubmed	MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.	MUC16 JAK2	2.02e-05	2	157	2	21785467
Pubmed	Annexin A5 increases the cell surface expression and the chloride channel function of the DeltaF508-cystic fibrosis transmembrane regulator.	ANXA5 CFTR	2.02e-05	2	157	2	18773956
Pubmed	Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18.	UNC13B UNC13A	2.02e-05	2	157	2	28772123
Pubmed	Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion.	UNC13B UNC13A	2.02e-05	2	157	2	17267576
Pubmed	Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).	CCNT1 PRKCI	2.02e-05	2	157	2	19208825
Pubmed	A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution.	UNC13B UNC13A	2.02e-05	2	157	2	35613050
Pubmed	Membrane bridging by Munc13-1 is crucial for neurotransmitter release.	UNC13B UNC13A	2.02e-05	2	157	2	30816091
Pubmed	Effect of Annexin A5 on CFTR: regulated traffic or scaffolding?	ANXA5 CFTR	2.02e-05	2	157	2	21067452
Pubmed	A common molecular basis for membrane docking and functional priming of synaptic vesicles.	UNC13B UNC13A	2.02e-05	2	157	2	19558619
Pubmed	Phorbol esters modulate spontaneous and Ca2+-evoked transmitter release via acting on both Munc13 and protein kinase C.	UNC13B UNC13A	2.02e-05	2	157	2	18701688
Pubmed	Population genetic data on D1S80, D17S5, ApoB, COL2A1 and Ig-JH in Northeastern Thais.	COL2A1 APOB	2.02e-05	2	157	2	16978902
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4 RASA4B	2.02e-05	2	157	2	16041389
Pubmed	Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs.	UNC13B UNC13A	2.02e-05	2	157	2	11792326
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	USP34 WFS1 OPN3 ANXA5 SHC1 TTC27 APOB BLVRA JAK2 CCNT1 MDN1 MROH1 GPR89A EGFL7 HERC1 IL6ST	2.67e-05	1061	157	16	33845483
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DMXL2 EMC1 DDX49 COPA MYCBP2 ANXA5 NOL12 DPF2 HNRNPL EHBP1L1 TCERG1 SUN2 MED23 AGRN TNXB UNC13A	3.38e-05	1082	157	16	38697112
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL2A1 ANXA5 COL5A3 EGFL7 AGRN TNXB	3.57e-05	135	157	6	28675934
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	USP34 TTC39B COPA BZW2 DPF2 PHF8 HNRNPL PPP2R1A LARP4B PLAA CEBPZ YPEL5 PWP2 PRKCI PCDH10	3.67e-05	971	157	15	33306668
Pubmed	Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.	PRKD3 PRKCH PRKCI	3.95e-05	15	157	3	8627654
Pubmed	[HIV-1 Tat protein induces IL-10 production by human monocytes: implications of the PKC and calcium pathway].	PRKD3 PRKCH PRKCI	4.84e-05	16	157	3	11833470
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 TCP11L1 NOL12 TTC27 CUL9 DPF2 PHF8 ABCA7 SLC4A1 CCNT1 LARP4B UTP25 SUN2 MGA CDH15 NOS1AP	4.87e-05	1116	157	16	31753913
Pubmed	CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.	RASA4 RASA4B	6.06e-05	3	157	2	25637021
Pubmed	Pro-alpha3(V) collagen chain is expressed in bone and its basic N-terminal peptide adheres to osteosarcoma cells.	COL2A1 COL5A3	6.06e-05	3	157	2	15908193
Pubmed	Selective binding of anchorin CII (annexin V) to type II and X collagen and to chondrocalcin (C-propeptide of type II collagen). Implications for anchoring function between matrix vesicles and matrix proteins.	COL2A1 ANXA5	6.06e-05	3	157	2	1397263
Pubmed	Identification of three novel non-classical cadherin genes through comprehensive analysis of large cDNAs.	CDH23 DCHS1	6.06e-05	3	157	2	11597768
Pubmed	Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein.	SHC1 JAK2	6.06e-05	3	157	2	8400282
Pubmed	Heterogeneous Presynaptic Distribution of Munc13 Isoforms at Retinal Synapses and Identification of an Unconventional Bipolar Cell Type with Dual Expression of Munc13 Isoforms: A Study Using Munc13-EXFP Knock-in Mice.	UNC13B UNC13A	6.06e-05	3	157	2	33105896
Pubmed	An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton.	CFTR SCN4A	6.06e-05	3	157	2	9677412
Pubmed	AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia.	RUNX1T1 JAK2	6.06e-05	3	157	2	17625612
Pubmed	YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1.	CFTR SHC1	6.06e-05	3	157	2	37371529
Pubmed	Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.	ABCA7 TREM2	6.06e-05	3	157	2	28789839
Pubmed	ShcA regulates thymocyte proliferation through specific transcription factors and a c-Abl-dependent signaling axis.	ABL2 SHC1	6.06e-05	3	157	2	25691660
Pubmed	Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming.	UNC13B UNC13A	6.06e-05	3	157	2	37343100
Pubmed	Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages.	ASAH2 TREM2	6.06e-05	3	157	2	38302493
Pubmed	The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse.	UNC13B UNC13A	6.06e-05	3	157	2	23658173
Pubmed	Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch.	SHC1 JAK2	6.06e-05	3	157	2	16437163
Pubmed	Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?	JAK2 IL6ST	6.06e-05	3	157	2	14996842
Pubmed	Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice.	ASAH2 CFTR	6.06e-05	3	157	2	18955860
Pubmed	Interaction between Munc13-1 and RIM is critical for glucagon-like peptide-1 mediated rescue of exocytotic defects in Munc13-1 deficient pancreatic beta-cells.	UNC13B UNC13A	6.06e-05	3	157	2	17639022
Pubmed	Genetic and structural studies of RABL3 reveal an essential role in lymphoid development and function.	GPR89B GPR89A	6.06e-05	3	157	2	32220963
Pubmed	SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.	JAK2 IL6ST	6.06e-05	3	157	2	23454976
Pubmed	Thrombopoietin signal transduction requires functional JAK2, not TYK2.	SHC1 JAK2	6.06e-05	3	157	2	10224114
Pubmed	Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells.	CDH23 CDH15	6.06e-05	3	157	2	17805295
Pubmed	Nonconserved Ca(2+)/calmodulin binding sites in Munc13s differentially control synaptic short-term plasticity.	UNC13B UNC13A	6.06e-05	3	157	2	22966208
Pubmed	Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse.	UNC13B UNC13A	6.06e-05	3	157	2	15988013
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	CDH23 ZNFX1 RUNX1T1 HMCN1 AGRN DNAH11	6.93e-05	152	157	6	34299191
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL2A1 LAMA1 EGFL7 AGRN	7.83e-05	50	157	4	23658023
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 TBC1D9B DYM EMC1 COPA BZW2 ANXA5 TTC27 HNRNPL BLVRA DNAAF5 PPP2R1A LARP4B MDN1 CEBPZ SUN2 GPR89A SLC27A4	9.43e-05	1440	157	18	30833792
Pubmed	Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway.	PRKD3 PRKCH PRKCI	9.72e-05	20	157	3	11044099
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TBC1D9B EMC1 COPA BZW2 WFS1 TTC27 DNAAF5 PPP2R1A LARP4B PLAA CEBPZ EGFL7 CEP97 SLC27A4	1.01e-04	942	157	14	31073040
Pubmed	Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.	PRKD3 PRKCH PRKCI	1.13e-04	21	157	3	9446795
Pubmed	Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways.	PRKD3 PRKCH PRKCI	1.13e-04	21	157	3	9671211
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	GPR89B USP34 EMC1 COPA MYCBP2 BZW2 WFS1 NAGA LAMA1 DCBLD1 LAMC3 ABCA7 SUN2 TLL1 AGRN IL6ST	1.14e-04	1201	157	16	35696571
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	ANXA5 LAMA1 COL5A3 HMCN1 EGFL7 AGRN	1.16e-04	167	157	6	22159717
Pubmed	Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo.	UNC13B UNC13A	1.21e-04	4	157	2	10488064
Pubmed	Parvovirus interference with intracellular signalling: mechanism of PKCeta activation in MVM-infected A9 fibroblasts.	PRKCH PRKCI	1.21e-04	4	157	2	18042254
Pubmed	Interaction of the protein phosphatase 2A with the regulatory domain of the cystic fibrosis transmembrane conductance regulator channel.	CFTR PPP2R1A	1.21e-04	4	157	2	15936019
Pubmed	Gq activity- and β-arrestin-1 scaffolding-mediated ADGRG2/CFTR coupling are required for male fertility.	CFTR ADGRG2	1.21e-04	4	157	2	29393851
Pubmed	Fbxo45, a novel ubiquitin ligase, regulates synaptic activity.	UNC13B UNC13A	1.21e-04	4	157	2	19996097
Pubmed	Cloning and characterization of mouse CCAAT binding factor.	LAMA1 CEBPZ	1.21e-04	4	157	2	8604343
Pubmed	Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding.	RASA4 RASA4B	1.21e-04	4	157	2	16234249
Pubmed	Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth.	ABL2 S1PR2	1.21e-04	4	157	2	25111230
Pubmed	Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.	COPA SHC1	1.21e-04	4	157	2	12586295
Pubmed	Ca2+-dependent monomer and dimer formation switches CAPRI Protein between Ras GTPase-activating protein (GAP) and RapGAP activities.	RASA4 RASA4B	1.21e-04	4	157	2	21460216
Pubmed	Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.	JAK2 IL6ST	1.21e-04	4	157	2	23818941
Pubmed	Organisation of extracellular matrix proteins laminin and agrin in pericapillary basal laminae in mouse brain.	LAMA1 AGRN	1.21e-04	4	157	2	32072250
GeneFamily	UNC13 homologs	UNC13B UNC13A	2.22e-04	4	111	2	836
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	1.63e-03	10	111	2	830
GeneFamily	Maestro heat like repeat containing	MROH1 MRO	1.98e-03	11	111	2	636
GeneFamily	DEAD-box helicases	DDX31 DDX49 DDX25	2.17e-03	42	111	3	499
GeneFamily	Laminin subunits	LAMA1 LAMC3	2.37e-03	12	111	2	626
GeneFamily	Fibronectin type III domain containing	IGFN1 TIE1 LRFN5 TNXB IL6ST	3.08e-03	160	111	5	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGFN1 LINGO2 HMCN1 LRFN5 CD101	3.16e-03	161	111	5	593
GeneFamily	SH2 domain containing	ABL2 SH2D3C SHC1 JAK2	3.48e-03	101	111	4	741
Coexpression	NABA_CORE_MATRISOME	COL2A1 LAMA1 TSPEAR KERA COL5A3 LAMC3 HMCN1 VWA2 AGRN TNXB	5.04e-06	270	155	10	MM17057
Coexpression	NABA_CORE_MATRISOME	COL2A1 LAMA1 TSPEAR KERA COL5A3 LAMC3 HMCN1 VWA2 AGRN TNXB	5.92e-06	275	155	10	M5884
Coexpression	HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS	LAMA1 HMCN1 EGFL7 AGRN	1.59e-05	26	155	4	M47999
Coexpression	NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS	ANXA5 MUC16 HMCN1 AGRN	2.86e-05	30	155	4	M47990
Coexpression	DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS	WFS1 LRRC32 SH2D3C SHC1 DCBLD1 LAMC3 TIE1 PRKCH EGFL7 VWA2 HBZ NOS2 AGRN TNXB	3.11e-05	645	155	14	M40158
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLK2 RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	1.33e-09	187	157	10	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	PLK2 LRRC32 SH2D3C RUNX1T1 TLL1 PRKCH EGFL7 CDRT15L2 TNXB	1.89e-08	183	157	9	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 RFX8 TIE1 TLL1 PRKCH EGFL7	1.98e-08	184	157	9	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	2.86e-08	192	157	9	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PIWIL1 SH2D3C TIE1 TLL1 DCHS1 PRKCH EGFL7 TNXB	3.12e-08	194	157	9	cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 SCN4A PRKCH EGFL7 NOS2	3.12e-08	194	157	9	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLK2 LRRC32 RUNX1T1 TIE1 RASA4 TLL1 RASA4B EGFL7 IL6ST	3.26e-08	195	157	9	81a98ebb0d43f416f9a8bba580531dc0cfea8f74
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.41e-08	196	157	9	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PLK2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.41e-08	196	157	9	ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.41e-08	196	157	9	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.41e-08	196	157	9	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.41e-08	196	157	9	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.41e-08	196	157	9	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.56e-08	197	157	9	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 SCN4A PRKCH EGFL7 TNXB	3.56e-08	197	157	9	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.72e-08	198	157	9	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.72e-08	198	157	9	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	3.72e-08	198	157	9	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLK2 LRRC32 SH2D3C TIE1 TLL1 DCHS1 EGFL7 TNXB IL6ST	3.72e-08	198	157	9	259fbcc0f2ac281a3e4d693de45b986fe5e24841
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C RUNX1T1 TIE1 RASA4 DCHS1 EGFL7 TNXB IL6ST	3.89e-08	199	157	9	da5a88749d859d535daa030d0974485906cc0ba7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PIWIL1 RUNX1T1 TIE1 TLL1 EGFL7 TNXB IL6ST	2.08e-07	175	157	8	90302e8a44858ef3b2a165b88284d4788d591a99
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	WFS1 SHC1 TSPEAR RUNX1T1 PKD1L3 TIE1 TNXB IL6ST	2.37e-07	178	157	8	ad3de3e03a401dac64431a541899445262246347
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	WFS1 LRRC32 RFX8 HMCN1 TIE1 DCHS1 NOS2 AGRN	2.81e-07	182	157	8	997d37ca2af661c92a56add888762724dfccc890
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SHC1 CDH23 TIE1 RASA4 TLL1 DCHS1 RASA4B EGFL7	2.93e-07	183	157	8	a644258ba90acc62d571623e429d72ffc4b69203
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 IGFN1 CFTR LAMA1 APOB HMCN1 PCDH10 DNAH11	3.05e-07	184	157	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 IGFN1 CFTR LAMA1 APOB HMCN1 PCDH10 DNAH11	3.05e-07	184	157	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 IGFN1 CFTR LAMA1 APOB HMCN1 PCDH10 DNAH11	3.05e-07	184	157	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	RASGRF2 LRRC32 RUNX1T1 HMCN1 TIE1 TLL1 EGFL7 PCDH10	3.31e-07	186	157	8	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	WFS1 SHC1 TSPEAR RUNX1T1 PKD1L3 TIE1 TNXB IL6ST	3.31e-07	186	157	8	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 DCBLD1 TIE1 ERCC6L2 DCHS1 PRKCH EGFL7 IL6ST	3.74e-07	189	157	8	ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	SH2D3C TSPEAR RUNX1T1 PKD1L3 TIE1 TLL1 EGFL7 TNXB	3.90e-07	190	157	8	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLK2 LRRC32 SH2D3C CDH23 TIE1 TLL1 PRKCH EGFL7	4.22e-07	192	157	8	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 SCN4A PRKCH EGFL7	4.22e-07	192	157	8	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C HMCN1 TIE1 TLL1 PRKCH EGFL7 TNXB	4.39e-07	193	157	8	1f978e102a029a6beb10913052cd0a20c7253e8e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7 TNXB	4.56e-07	194	157	8	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PIWIL1 SH2D3C TIE1 TLL1 PRKCH EGFL7 TNXB	4.56e-07	194	157	8	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PIWIL1 SH2D3C TIE1 TLL1 PRKCH EGFL7 TNXB	4.56e-07	194	157	8	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	RASGRF2 LRRC32 SH2D3C HMCN1 TIE1 TLL1 PRKCH EGFL7	4.75e-07	195	157	8	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRF2 LRRC32 SH2D3C TIE1 RASA4 PRKCH EGFL7 IL6ST	4.75e-07	195	157	8	4db30b3bc65c25626f828cd4f867f20c71809898
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 PRKCH EGFL7 NOS2	4.93e-07	196	157	8	023312af38f816a44b407e0daa32590d953caf99
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLK2 LRRC32 TIE1 RASA4 TLL1 DCHS1 EGFL7 IL6ST	4.93e-07	196	157	8	d5d3028fcbfa251a206d17ec33b3b313968f9d79
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7	4.93e-07	196	157	8	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C HMCN1 TIE1 TLL1 PRKCH EGFL7 TNXB	4.93e-07	196	157	8	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C HMCN1 TIE1 TLL1 PRKCH EGFL7 TNXB	5.13e-07	197	157	8	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 PRKCH EGFL7 TNXB	5.13e-07	197	157	8	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	RASGRF2 LRRC32 SH2D3C HMCN1 TIE1 TLL1 PRKCH EGFL7	5.13e-07	197	157	8	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C HMCN1 TIE1 TLL1 PRKCH EGFL7 TNXB	5.13e-07	197	157	8	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	RASGRF2 LRRC32 SH2D3C RUNX1T1 TIE1 PRKCH EGFL7 TNXB	5.33e-07	198	157	8	8689090bce9ab6e8f122426a404037e572c6713b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 RUNX1T1 TIE1 TLL1 DCHS1 EGFL7 TNXB IL6ST	5.53e-07	199	157	8	f35e9c05d0a0339ff691b38564da7aad8e9218aa
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Vein\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PLK2 LRRC32 HMCN1 TIE1 RASA4 TLL1 PRKCH EGFL7	5.75e-07	200	157	8	7eb366b2c5394af7c77650bde6261e7dac67154e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C RUNX1T1 TIE1 DCHS1 EGFL7 TNXB IL6ST	5.75e-07	200	157	8	b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C RUNX1T1 TIE1 DCHS1 EGFL7 TNXB IL6ST	5.75e-07	200	157	8	dba96cda5f3b780a3d4171b61bc8aaddc1f5d466
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	KERA COL5A3 RUNX1T1 ADGRG2 FIBIN LRFN5 GFPT2 TNXB	5.75e-07	200	157	8	64d2941689d7ca8af54f9ba21c5aeabf719084ef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C RUNX1T1 TIE1 DCHS1 EGFL7 TNXB IL6ST	5.75e-07	200	157	8	2e47888e041ec3d265425d1df97b6665c6da889c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C RUNX1T1 TIE1 DCHS1 EGFL7 TNXB IL6ST	5.75e-07	200	157	8	7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	PLK2 EHBP1L1 HMCN1 TIE1 RASA4 TLL1 EGFL7 PCDH10	5.75e-07	200	157	8	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	KERA COL5A3 RUNX1T1 ADGRG2 FIBIN LRFN5 GFPT2 TNXB	5.75e-07	200	157	8	76f3043cb88071256ff661885fe5a82a54f5b733
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ABL2 LAMA1 S1PR2 LAMC3 FIBIN SCN4A TNXB	1.58e-06	159	157	7	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 SH2D3C TIE1 TLL1 PRKCH EGFL7 TNXB	1.78e-06	162	157	7	c399b9e4854916a59f5cae2d8dbf19660f8759be
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 SH2D3C TIE1 TLL1 PRKCH EGFL7 TNXB	1.78e-06	162	157	7	a291248b693c771845174393934a782f1d8bd7ce
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ABL2 LAMA1 KERA COL5A3 SCN4A TNXB	1.88e-06	104	157	6	11d91471b6c4fa6b00a91d9fd4db72ee60d1f801
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ABL2 LAMA1 KERA COL5A3 SCN4A TNXB	1.88e-06	104	157	6	424a58b04c8b5108b70f15d8353c8e4b9db1e730
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ABL2 LAMA1 KERA COL5A3 SCN4A TNXB	1.88e-06	104	157	6	9b05ae514437eb0c8b1b23607ae8cbc371ffa85b
ToppCell	Endothelial-endothelial_cell_of_bronchial_vessel\|World / Lineage, Cell type, age group and donor	RASGRF2 SH2D3C RUNX1T1 TIE1 TLL1 PRKCH EGFL7	2.02e-06	165	157	7	84e553d699ac56df89a77248f7308b9133e1b683
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRC32 RUNX1T1 RASA4 LRFN5 DCHS1 RASA4B EGFL7	2.46e-06	170	157	7	1a568efcff9c39b3f709b55a05d24710450a2657
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRC32 RUNX1T1 RASA4 LRFN5 DCHS1 RASA4B EGFL7	2.46e-06	170	157	7	66d41d794790e621d72ac37af995510537103c9c
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRRC32 SH2D3C COL5A3 LAMC3 ARHGEF17 CENPP AGRN	3.33e-06	178	157	7	e5e4742e35c3d90f82b830d77bdbdc45828c7deb
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	TSPEAR RUNX1T1 PKD1L3 TIE1 TLL1 EGFL7 TNXB	3.33e-06	178	157	7	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	WFS1 SHC1 TSPEAR TIE1 TLL1 EGFL7 TNXB	3.46e-06	179	157	7	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	Endothelial-A-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	LRRC32 SH2D3C TIE1 DCHS1 EGFL7 NOS2 TNXB	3.59e-06	180	157	7	4c3376169770ee9f9283daae44c17f35e46bfd19
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WFS1 SH2D3C TSPEAR TIE1 PRKCH EGFL7 TNXB	3.86e-06	182	157	7	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WFS1 SH2D3C TSPEAR TIE1 PRKCH EGFL7 TNXB	3.86e-06	182	157	7	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WFS1 SH2D3C TSPEAR TIE1 PRKCH EGFL7 TNXB	3.86e-06	182	157	7	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WFS1 SHC1 TSPEAR TIE1 TLL1 EGFL7 TNXB	4.00e-06	183	157	7	764ea07621f77fbd13a877aed5806ae2b3dfb43e
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	WFS1 SHC1 TSPEAR RUNX1T1 TIE1 TNXB IL6ST	4.00e-06	183	157	7	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C HMCN1 TIE1 TLL1 EGFL7 NOS2	4.00e-06	183	157	7	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 SH2D3C HMCN1 TIE1 TLL1 EGFL7 NOS2	4.00e-06	183	157	7	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	Endothelial-A-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	PLK2 LRRC32 SH2D3C TIE1 TLL1 DCHS1 EGFL7	4.00e-06	183	157	7	2c3f2c25c38f0598b4787d2ec335efe00fdc9751
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH2D3C TSPEAR TIE1 TLL1 PRKCH EGFL7 TNXB	4.00e-06	183	157	7	bc98df870de65aff6dab295c24cbc199c7f2aa15
ToppCell	droplet-Trachea-nan-3m-Endothelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 RASGRF2 LRRC32 SH2D3C TIE1 PRKCH EGFL7	4.15e-06	184	157	7	fa5c3020e75fdde1363393dea97ebd99f1eae9ff
ToppCell	droplet-Trachea-3m-Endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLK2 RASGRF2 LRRC32 SH2D3C TIE1 PRKCH EGFL7	4.15e-06	184	157	7	ad520ab6bb776b5303df505b7e1afb22484f18a7
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ABL2 MYCBP2 ITGA4 HMCN1 LRFN5 TLL1 IL6ST	4.15e-06	184	157	7	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	droplet-Trachea-nan-3m-Endothelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 RASGRF2 LRRC32 SH2D3C TIE1 PRKCH EGFL7	4.15e-06	184	157	7	1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645
ToppCell	droplet-Trachea-nan-3m-Endothelial-endothelial_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 RASGRF2 LRRC32 SH2D3C TIE1 PRKCH EGFL7	4.15e-06	184	157	7	76caad53d55fff5acca27bf190a6de7b27437d9f
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLK2 RASGRF2 LRRC32 SH2D3C TIE1 PRKCH EGFL7	4.15e-06	184	157	7	1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLK2 RASGRF2 LRRC32 SH2D3C TIE1 PRKCH EGFL7	4.15e-06	184	157	7	2467207aaea307873ab286f89cfc7668a227a694
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RASGRF2 LRRC32 RUNX1T1 HMCN1 TIE1 TLL1 EGFL7	4.30e-06	185	157	7	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRRC32 SH2D3C COL5A3 LAMC3 ARHGEF17 AGRN DNAH11	4.45e-06	186	157	7	6568358812f0ca4e0161a1a1b29682fbced35c79
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLK2 RASGRF2 HMCN1 TIE1 TLL1 PRKCH PCDH10	4.45e-06	186	157	7	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	RASGRF2 SH2D3C HMCN1 TIE1 PRKCH EGFL7 IL6ST	4.61e-06	187	157	7	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	SH2D3C TSPEAR RUNX1T1 PKD1L3 TIE1 TLL1 EGFL7	4.61e-06	187	157	7	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLK2 LRRC32 HMCN1 TIE1 TLL1 EGFL7 IL6ST	4.78e-06	188	157	7	5eb107122064f0a99dfd445cc87d3766f7257216
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLK2 SH2D3C TIE1 SCN4A PRKCH EGFL7 AGRN	4.78e-06	188	157	7	0026c9479b30fb39daa91cfa220a88f9c9e65fe7
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	RASGRF2 LRRC32 RUNX1T1 HMCN1 TIE1 TLL1 EGFL7	4.95e-06	189	157	7	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	LRRC32 SH2D3C COL5A3 LAMC3 ITGA4 ARHGEF17 DNAH11	4.95e-06	189	157	7	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL5A3 RUNX1T1 ADGRG2 LRFN5 TLL1 GFPT2 TNXB	4.95e-06	189	157	7	c392491aabe8a3e90974ab2ea123bbbe5200439d
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	RASGRF2 HMCN1 TIE1 TLL1 PRKCH EGFL7 IL6ST	4.95e-06	189	157	7	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRRC32 HMCN1 TIE1 TLL1 PRKCH EGFL7 AGRN	4.95e-06	189	157	7	fccadf8efbef17b7f12291b069c71060a71b04e2
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLK2 RASGRF2 LRRC32 SH2D3C TIE1 PRKCH EGFL7	4.95e-06	189	157	7	28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	WFS1 SH2D3C TSPEAR TIE1 PRKCH EGFL7 TNXB	5.12e-06	190	157	7	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
Drug	AC1L1B58	LAMA1 LAMC3 PRKD3 PRKCH PRKCI	1.30e-06	29	152	5	CID000001288
Drug	enzastaurin	COL2A1 ANXA5 PRKD3 PRKCH PRKCI EGFL7	1.42e-06	53	152	6	CID000176166
Drug	H-9 dihydrochloride	CFTR LAMA1 LAMC3 PRKD3 CCNT1 PRKCH PRKCI	2.42e-06	90	152	7	CID000003544
Drug	broussochalcone A	PRKD3 PRKCH PRKCI NOS2	1.05e-05	21	152	4	CID006438825
Drug	lavendustin A	CFTR PKD1L3 GRM5 PRKD3 JAK2 PRKCH PRKCI NOS2	2.01e-05	171	152	8	CID000003894
Drug	taxol	ANXA5 CFTR LAMA1 LAMC3 PKD1L3 PRKD3 TCERG1 CHFR PCYT2 PRKCH PRKCI EGFL7 NOS2 IL6ST	2.45e-05	560	152	14	CID000004666
Drug	auranofin	COL2A1 PRKD3 PRKCH PRKCI NOS2	2.51e-05	52	152	5	CID006918453
Drug	Ridauran	COL2A1 PRKD3 PRKCH PRKCI NOS2	3.30e-05	55	152	5	CID006333887
Drug	SP600125	IL25 ANXA5 S1PR2 RUNX1T1 GRM5 PRKD3 JAK2 PRKCH PRKCI NOS2 IL6ST	3.31e-05	362	152	11	CID000008515
Drug	bisindolylmaleimide II	ANXA5 PRKD3 PRKCH PRKCI	3.45e-05	28	152	4	CID000002397
Drug	bisindolylmaleimide V	ANXA5 PRKD3 PRKCH PRKCI	3.45e-05	28	152	4	CID000002400
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	USP34 DDX49 PRKD3 JAK2 EHBP1L1 CEBPZ LRRC61 SLC6A14	3.82e-05	187	152	8	5598_DN
Drug	N,N-diphenyl urea	ITGA4 ADH7	4.43e-05	2	152	2	CID000033603
Drug	18alpha-olean-12-ene-3beta-23,28-triol	COL2A1 NOS2	4.43e-05	2	152	2	CID000154204
Drug	AG126	PRKD3 JAK2 PRKCH PRKCI EGFL7 NOS2	4.53e-05	96	152	6	CID000002046
Drug	AC1L3G0K	ANXA5 PRKD3 PRKCH PRKCI	4.57e-05	30	152	4	CID000114822
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	USP34 TBC1D9B BLVRA JAK2 DYNC2LI1 PRKCH AGRN IL6ST	4.95e-05	194	152	8	1642_DN
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	USP34 DMXL2 EMC1 BLVRA JAK2 EHBP1L1 IL6ST NOS1AP	4.95e-05	194	152	8	3366_DN
Drug	PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A	CWH43 CHI3L2 RUNX1T1 ARHGEF17 JAK2 LRRC61 AGRN UNC13A	5.32e-05	196	152	8	3827_UP
Drug	AC1L1J0H	ANXA5 ITGA4 PRKD3 JAK2 PRKCH PRKCI NOS2 IL6ST	5.52e-05	197	152	8	CID000004813
Disease	Congenital bilateral aplasia of vas deferens	CFTR ADGRG2	2.43e-05	2	146	2	C0403814
Disease	Vertigo	TTC39B CDH23 LINGO2 RFX8 GRM5 NOS2	6.92e-05	139	146	6	HP_0002321
Disease	inflammatory bowel disease (biomarker_via_orthology)	NOS2 SLC6A14	7.27e-05	3	146	2	DOID:0050589 (biomarker_via_orthology)
Disease	Polyarthritis	COL2A1 COPA	2.41e-04	5	146	2	C0162323
Disease	Arthritis	COL2A1 COPA	3.60e-04	6	146	2	C0003864
Disease	3-hydroxypropylmercapturic acid measurement	USP34 PLK2 DYM CFTR LINGO2 ADGRG2 ERCC6L2 PRKCI	3.83e-04	352	146	8	EFO_0007014
Disease	LDL cholesterol change measurement	APOB PKD1L3	5.02e-04	7	146	2	EFO_0007804
Disease	eating disorder	RASGRF2 SH2D3C ADH7	5.30e-04	32	146	3	EFO_0005203
Disease	cleft lip	WFS1 MUC16 GRM5 ADH7 UTP25 SERPINA13P ERCC6L2	5.52e-04	284	146	7	EFO_0003959
Disease	marginal zone B-cell lymphoma	APOB PRKCH	6.68e-04	8	146	2	EFO_1000630
Disease	visceral heterotaxy (implicated_via_orthology)	PSME4 DAW1 DNAH11	8.15e-04	37	146	3	DOID:0050545 (implicated_via_orthology)
Disease	Hereditary hearing loss and deafness	COL2A1 WFS1 CDH23 S1PR2 SCN4A	8.16e-04	146	146	5	cv:C0236038
Disease	interleukin-36 alpha measurement	EGFL7 TNXB	8.56e-04	9	146	2	EFO_0021851
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	TTC39B NYAP2 APOB PKD1L3 ADH7 CDH15 DNAH11	8.72e-04	307	146	7	EFO_0004612, EFO_0020946
Disease	neutrophil percentage of leukocytes	COL2A1 NYAP2 SH2D3C CDH23 ITGA4 ABCA7 SLC4A1 PRKD3 EGFL7 SERTAD3	9.51e-04	610	146	10	EFO_0007990
Disease	alcohol consumption measurement	NRBP1 NYAP2 DDX31 RASGRF2 LAMC3 LINGO2 ITGA4 RUNX1T1 PKD1L3 GRM5 DERA ADH7 LRFN5 MGA AGRN	1.30e-03	1242	146	15	EFO_0007878
Disease	risky sexual behaviour measurement	TTC27 LINGO2 RUNX1T1 PKD1L3 DERA	1.56e-03	169	146	5	EFO_0007877
Disease	obesity (is_marker_for)	APOB JAK2 NOS2 SLC27A4	1.62e-03	101	146	4	DOID:9970 (is_marker_for)
Disease	Celiac Disease	ASAH2 APOB SLC6A14	1.64e-03	47	146	3	C0007570
Disease	Leukemia, Myelocytic, Acute	ANXA5 RUNX1T1 FANCM JAK2 AGRN	1.73e-03	173	146	5	C0023467
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 CDH23	1.83e-03	13	146	2	C1846647
Disease	putamen volume change measurement	SH2D3C DCHS1	1.83e-03	13	146	2	EFO_0021495
Disease	hepatocellular carcinoma (biomarker_via_orthology)	SHC1 JAK2 NOS2 IL6ST	2.07e-03	108	146	4	DOID:684 (biomarker_via_orthology)
Disease	Kartagener syndrome (implicated_via_orthology)	DAW1 DNAH11	2.13e-03	14	146	2	DOID:0050144 (implicated_via_orthology)
Disease	complex trait	NRBP1 DMXL2 DYM DCBLD1 APOB CHFR	2.36e-03	271	146	6	EFO_0010578
Disease	Mouth Neoplasms	ANXA5 LAMC3 ADH7	2.45e-03	54	146	3	C0026640
Disease	Malignant neoplasm of mouth	ANXA5 LAMC3 ADH7	2.45e-03	54	146	3	C0153381
Disease	glycerate measurement	HMCN1 AGRN	2.45e-03	15	146	2	EFO_0021029
Disease	amenorrhea, response to antineoplastic agent	APOB DERA	2.45e-03	15	146	2	EFO_0010269, GO_0097327
Disease	Drug habituation	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C0013170
Disease	Drug abuse	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C0013146
Disease	Prescription Drug Abuse	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C4316881
Disease	Substance-Related Disorders	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C0236969
Disease	Drug Use Disorders	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C0013222
Disease	Drug Dependence	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C1510472
Disease	Substance Dependence	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C0038580
Disease	Substance Use Disorders	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	PIWIL1 CFTR GRM5 PRKCH	2.60e-03	115	146	4	C0029231
Disease	Colorectal Carcinoma	UNC13B RASGRF2 CFTR LAMA1 TSPEAR APOB RUNX1T1 DCHS1 VWA2 IL6ST	2.67e-03	702	146	10	C0009402
Disease	Substance abuse problem	PIWIL1 CFTR GRM5 PRKCH	2.68e-03	116	146	4	C0740858
Disease	Myasthenic Syndromes, Congenital, Slow Channel	SCN4A AGRN	2.79e-03	16	146	2	C0751885
Disease	endoplasmic reticulum resident protein 29 measurement	EGFL7 TNXB	2.79e-03	16	146	2	EFO_0020346
Disease	Malaria, susceptibility to	SLC4A1 NOS2	2.79e-03	16	146	2	cv:C1970028
Disease	–	SLC4A1 NOS2	2.79e-03	16	146	2	611162
Disease	free cholesterol in medium HDL measurement	TTC39B NYAP2 APOB	3.00e-03	58	146	3	EFO_0022267
Disease	Congenital Myasthenic Syndromes, Postsynaptic	SCN4A AGRN	3.15e-03	17	146	2	C0751883
Disease	cholesterol in medium HDL measurement	TTC39B NYAP2 APOB	3.15e-03	59	146	3	EFO_0021903
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	NYAP2 APOB AGRN	3.15e-03	59	146	3	EFO_0022260
Disease	cholesterol to total lipids in medium HDL percentage	TTC39B NYAP2 APOB	3.30e-03	60	146	3	EFO_0022237
Disease	free cholesterol to total lipids in medium HDL percentage	TTC39B NYAP2 APOB	3.30e-03	60	146	3	EFO_0022282
Disease	apolipoprotein A 1 measurement	TTC39B NYAP2 DYM APOB LINGO2 PKD1L3 GRM5 ADH7 HERC1 MED23 MGA	3.38e-03	848	146	11	EFO_0004614
Disease	free cholesterol in HDL measurement	TTC39B NYAP2 APOB	3.46e-03	61	146	3	EFO_0022264
Disease	phospholipids in HDL measurement	TTC39B NYAP2 APOB	3.46e-03	61	146	3	EFO_0022293
Disease	Acute Myeloid Leukemia, M1	ANXA5 RUNX1T1 JAK2 AGRN	3.51e-03	125	146	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	ANXA5 RUNX1T1 JAK2 AGRN	3.51e-03	125	146	4	C1879321
Disease	neutrophil count	GPR89B COPA MYCBP2 CDH23 S1PR2 ITGA4 ABCA7 CENPP JAK2 TIE1 CD101 GPR89A TNXB SERTAD3 NOS1AP	3.61e-03	1382	146	15	EFO_0004833
Disease	total lipids in chylomicrons and extremely large VLDL measurement	NYAP2 APOB AGRN	3.63e-03	62	146	3	EFO_0022306
Disease	free cholesterol in very large HDL measurement	TTC39B NYAP2 APOB	3.63e-03	62	146	3	EFO_0022273
Disease	Inflammation	COL2A1 JAK2 PLAA NOS2	3.71e-03	127	146	4	C0021368
Disease	total lipids in HDL measurement	TTC39B NYAP2 APOB	3.79e-03	63	146	3	EFO_0022307
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	NYAP2 APOB AGRN	3.79e-03	63	146	3	EFO_0022292
Disease	X-11470 measurement	TTC27 TNXB	3.93e-03	19	146	2	EFO_0021241
Disease	Congenital Myasthenic Syndromes, Presynaptic	SCN4A AGRN	3.93e-03	19	146	2	C0751884
Disease	osteochondrodysplasia (is_implicated_in)	COL2A1 DYM	3.93e-03	19	146	2	DOID:2256 (is_implicated_in)
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	TTC39B NYAP2 TTC27 APOB ADH7 DNAH11	4.08e-03	303	146	6	EFO_0004612, EFO_0020945
Disease	total lipids in very large HDL measurement	TTC39B NYAP2 APOB	4.32e-03	66	146	3	EFO_0022312
Disease	phospholipids in very large HDL measurement	TTC39B NYAP2 APOB	4.32e-03	66	146	3	EFO_0022298
Disease	Malaria	SLC4A1 NOS2	4.36e-03	20	146	2	C0024530
Disease	eye colour measurement	NYAP2 MYCBP2 CENPP ERCC6L2 NOS1AP	4.67e-03	218	146	5	EFO_0009764
Disease	diabetes mellitus	NYAP2 MYCBP2 WFS1	4.70e-03	68	146	3	EFO_0000400
Disease	cholesterol in very large HDL measurement	TTC39B NYAP2 APOB	4.90e-03	69	146	3	EFO_0022229

Protein segments in the cluster

Peptide	Gene	Start	Entry
NDTLAGRLTLSTFTL	UPK3BL1	51	B0FP48
SDDFLGQTIIEVRTL	UNC13A	761	Q9UPW8
LLALAEQLGTFTTLV	PPP2R1A	66	P30153
FELLNSGQSIRTVLT	ADH7	371	P40394
ELSDFLRVQQSLGTR	BZW2	241	Q9Y6E2
LAQTDGTLSTLEFQR	CHMP4A	76	Q9BY43
ERLLSFAGTTALLLQ	CDRT15L2	201	A8MXV6
QLGRIDSLSEQISFL	EGFL7	246	Q9UHF1
STLLSAFLRLLNTEG	CFTR	1251	P13569
LRGFDLSELERTNST	CSMD2	2086	Q7Z408
LLSSLINGSFLVRES	ABL2	186	P42684
GVTSLSGIQLFDRIL	SLC4A1	796	P02730
LTSFGVLLDLSRTSV	ADGRG2	606	Q8IZP9
FELSLRTEATQGLVL	AGRN	1916	O00468
EFLTVTSNTLFRTLL	DNAH11	4216	Q96DT5
DSSTSRLEFINSIIL	CHI3L2	116	Q15782
LESIILQTLGFELTI	CCNT1	136	O60563
VLLRSIDLVSSVDGT	DMXL2	1231	Q8TDJ6
DLESLVQFLSLGTLL	SLC7A4	386	O43246
LGTDEESILTLLTSR	ANXA5	31	P08758
SSLVSLLEEIELIFG	CCDC87	781	Q9NVE4
INARSGEITTTSLLD	CDH23	721	Q9H251
ELSFLSTLTGINIRN	CENPP	66	Q6IPU0
SLLSGELTVEQRASI	DDX25	366	Q9UHL0
VAELLTSLLRTESLG	ABCA7	156	Q8IZY2
TFLRLLSTEGSQNIT	COL2A1	1376	P02458
LLFQLELSRTSETNT	RASA4	326	O43374
TVTTISDLDLSGARL	NOL12	106	Q9UGY1
LLFQLELSRTSETNT	RASA4B	326	C9J798
NLEIELSSLREALSF	JAK2	351	O60674
LSSLREALSFVSLID	JAK2	356	O60674
GAVELSLSEFLLLFT	CDC42BPG	1281	Q6DT37
SLVDLTLSRNTISFI	LRFN5	76	Q96NI6
DIASETLTLLSFLRS	ARHGEF17	466	Q96PE2
EEERLLLVVTSTFGN	NOS2	581	P35228
SLFTLLVTGTSRVDL	MUC16	11821	Q8WXI7
LFSLDAVSGLLQTLR	DCHS1	836	Q96JQ0
SSSLGLQDFDLLRVI	PRKCI	246	P41743
LLVSTLQAFIEGSSL	MDN1	3866	Q9NU22
LEQSIEFIRDSLISS	GRM5	106	P41594
SLILTRAFSEIQGLT	MGA	2461	Q8IWI9
LVLGLVNSTLTIEEF	RUNX1T1	151	Q06455
LKSRTGEFSLESILL	LRRC61	21	Q9BV99
DLVVLLFETALLSSG	HSP90AB3P	526	Q58FF7
ALLSLLFITSGTIEN	ASAH2	26	Q9NR71
SEREALLVGIISTFL	ENOX2	531	Q16206
EITSGLEVISSLRAI	FANCM	1826	Q8IYD8
RGLTASVLLDLTYLT	HERC1	2386	Q15751
TEDLFENRLSSLIIG	LARP4B	546	Q92615
ITGDTLRTFSLVLVL	DYNC2LI1	101	Q8TCX1
FRQIDSGSNLTTDLI	PCYT2	331	Q99447
LFLLSVSDIGLVTAL	OR51S1	71	Q8NGJ8
EFILRGLSSSLELQI	OR4K3	11	Q96R72
GNLLILVTVTFDSLL	OR4K13	41	Q8NH42
GNFLIILTVTSDSRL	OR4K15	41	Q8NH41
ILLGLTSSQDVEFLL	OR4K17	16	Q8NGC6
RERLLSVQQDFTSGL	DTNBP1	6	Q96EV8
ESTALRLITALGSSE	MED23	646	Q9ULK4
EIISLSFNTSGDRII	DAW1	221	Q8N136
QAELSLTLSGVLLRE	EHBP1L1	146	Q8N3D4
SFLLQIGLTRESVTI	PRKD3	61	O94806
RAFSGLLSLEQLTLE	LINGO2	171	Q7L985
LGSFFIDITLQTRTL	MRO	126	Q9BYG7
LEELTSLFSSGRSLL	NYAP2	511	Q9P242
DISGNEFILLVTTTL	OR13C5	191	Q8NGS8
TGTALLTIRVLDSND	PCDH10	231	Q9P2E7
LSATLTEGVTRLADI	DDX31	421	Q9H8H2
SVGSRTLETQLDALL	MROH1	296	Q8NDA8
LLASTESIRLEVGVT	IRGC	46	Q6NXR0
VSSISQLRTGALFIL	HMCN1	841	Q96RW7
LGFISEADQSRLTSL	NRBP1	496	Q9UHY1
VLLGLRDTSDSIVAI	SCYL3	381	Q8IZE3
GITSLRSLSLVDNEI	LRRC32	441	Q14392
VNISLSDLLVSLFGV	OPN3	81	Q9H1Y3
ERLITLGFGNITTVL	OTOP1	231	Q7RTM1
QADTIGTETLERLFL	HBZ	21	P02008
VLLDQLGTTISFERI	APOB	2296	P04114
LGTTISFERINDILE	APOB	2301	P04114
TESLVALQRGVFLLS	CHFR	576	Q96EP1
LAVISRGLLSQSLEF	IGLON5	21	A6NGN9
TFRLSIERLQSSDQG	CD101	231	Q93033
ALFIFLTTESTGELL	IL6ST	11	P40189
ISQSGETADTLLALR	GFPT2	421	O94808
SERVLTEISLGSLLI	DYM	426	Q7RTS9
ELIIFEILGVLNSSS	GPR89A	56	B7ZAQ6
ELIIFEILGVLNSSS	GPR89B	56	P0CG08
EIRDLNEISFLASLT	CEP97	181	Q8IW35
TGNLLLRDADSITLF	COPA	461	P53621
STELTRQTLDLLGLI	GPR37L1	386	O60883
SRTLGELESLNTVLS	C1orf112	566	Q9NSG2
SSLTQEELARLLQFT	AREL1	741	O15033
EELARLLQFTTGSSQ	AREL1	746	O15033
LVSLFGELSLVSATL	BLVRA	176	P53004
LSRIDISFLLDVSSL	ITGA4	721	P13612
ISFLLDVSSLSRAEE	ITGA4	726	P13612
DDSRSVNSVLLFTIL	HNRNPL	186	P14866
SLLQVLSSRFEGSTL	CUL9	546	Q8IWT3
QTLLFSATLTDTLRE	DDX49	181	Q9Y6V7
SATLTDTLRELQGLA	DDX49	186	Q9Y6V7
RLGEDSSLISLFLQV	IL25	6	Q9H293
LSDSGLYTVVLRTLQ	IGFN1	1011	Q86VF2
ETGRRLLDTTITFSL	EMC1	381	Q8N766
FSILSTVLLRATDTI	DNAAF5	626	Q86Y56
VISLLGDTSILDDLF	ERCC6L2	1446	Q5T890
SQDSLLEITFRSGAL	NOS1AP	371	O75052
LLLNTSEVTVRFESG	DCBLD1	121	Q8N8Z6
QVGSLLSLTLREEFT	FIBIN	71	Q8TAL6
FRIGASTLLSDIERQ	DERA	286	Q9Y315
FVANTLLSGSVTLRL	S1PR2	86	O95136
LFSIDELTGEIRTVQ	CDH15	201	P55291
TLDLSGIRLTNYSLV	PRAMEF26	231	H0Y7S4
VTTGLNATILERSLD	COL5A3	311	P25940
SGEVERLLFRSNISS	CEBPZ	421	Q03701
FILSSILGISTTEGR	OR8A1	236	Q8NGG7
ALAILLGRSQTISFT	OR6F1	81	Q8NGZ6
TLLRIITIGSIASFQ	CWH43	71	Q9H720
DSNLLSFSGRILQTE	PIWIL1	446	Q96J94
EQLTILGAVLLVTFS	TCP11L1	341	Q9NUJ3
LRVVQLFISLLEGDS	UTP25	366	Q68CQ4
NDTLAGRLTLSTFTL	UPK3BL2	51	E5RIL1
LTEFVDLGNISALRT	SCN4A	206	P35499
LVSERGSRLELSFQT	TLL1	921	O43897
DILLDTSQTFIRQGS	RASGRF2	451	O14827
ITLEFRTSSQNGVLL	LAMA1	2916	P25391
SRGFDVSSILDLQLS	KERA	256	O60938
LYIRTSIILGSELNS	PKD1L3	11	Q7Z443
SLFQLLLEITVRSTG	MYCBP2	251	O75592
LSATIGSILRELDTS	SERTAD3	91	Q9UJW9
LLVGTLDVVLDSSAR	TBC1D9B	41	Q66K14
DTILTNRSELISTRF	YPEL5	21	P62699
FSSLLSRGSLEQLSE	TTC39B	216	Q5VTQ0
LTTAASLLDVFVLTR	SUN2	191	Q9UH99
FRQLLDETSAITLTS	TCERG1	961	O14776
VSTTEVEGTLSRLLD	SLC27A4	516	Q6P1M0
ETILQFSSGTLTLTR	TIE1	806	P35590
TTEGLLIYSLDTRVL	PWP2	721	Q15269
NLISLLGTSTDLRVF	RFX8	356	Q6ZV50
GELTVTDRTSDSLLL	TNXB	1066	P22105
ATFRLLVALGTLISD	PLAA	741	Q9Y263
RVDLLFLLDSSAGTT	VWA2	341	Q5GFL6
LISQDGSSLEALLRT	DPF2	111	Q92785
RTQLLEGLGFTLTVV	SERPINA13P	96	Q6UXR4
DDFLGQTIIEVRTLS	UNC13B	686	O14795
GRSFSTAVTEQLQLL	PSME4	1586	Q14997
DDTLGGTLTITLRNL	TREM2	86	Q9NZC2
FLSELTRGSTLLNFT	TLR6	241	Q9Y2C9
LSFTSQELSDLRSEI	ZNFX1	1746	Q9P2E3
FTSGQTSVTLRELLL	ZNF264	576	O43296
VISLEFSDTRLSNLV	PHF8	226	Q9UPP1
RISLTQAGLEALFES	PSMD5	151	Q16401
LIRDSLTSLGDYVLT	SH2D3C	241	Q8N5H7
VTFLLVVGERLATSL	TBC1D20	151	Q96BZ9
LSTNSETLGIEVFRI	TSPEAR	321	Q8WU66
INEDRISTTFRLTTL	PLK2	646	Q9NYY3
TGDLVELLSIFLSVL	USP34	2991	Q70CQ2
TTERQQLIFLLGVSS	TTC27	86	Q6P3X3
LLTLGLDSQFASIET	SLC6A14	416	Q9UN76
QIFLLSSDESTVRLL	USP40	396	Q9NVE5
LLQLNGDFLVRESTT	SHC1	501	P29353
SLRQGSLIEFSTILE	WFS1	816	O76024
SLIEFSTILEGRLGS	WFS1	821	O76024
STELLISLDRLNTFG	LAMC3	231	Q9Y6N6
LTGSFTEATLQRDRI	PRKCH	136	P24723
IISGLRDETNFTVII	NAGA	376	P17050